Reston, VA — The Society of Nuclear Medicine and Molecular Imaging recognized 15 new SNMMI Fellows on Monday, June 13, during a plenary session at the society’s 2022 Annual Meeting, held June 11-14. The SNMMI Fellowship was established in 2016 to recognize distinguished service to the society as well as exceptional achievement in the field of nuclear medicine and molecular imaging. It is among the most prestigious formal recognitions available to long-time SNMMI members.
All past SNMMI presidents were granted Fellowship at the 2016 Annual Meeting. Now SNMMI’s 2021-22 president, Richard Wahl, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, has joined their ranks. Also recognized were:
Abass Alavi, MD, Hospital of the University of Pennsylvania, University of Pennsylvania; Philadelphia, Pennsylvania
Johannes Czernin, MD, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
Farrokh Dehdashti, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
Yuni Dewaraja, PhD, University of Michigan Medical School, Ann Arbor, Michigan
Cameron Foster, MD, University of California Davis Health, Sacramento, California
Warren Janowitz, MD, JD, Radiology Associates of South Florida, Baptist Health, Miami, Florida
Neeta Pandit-Taskar, MD, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York
Daniel Pryma, MD, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, Pennsylvania
Lalitha Shankar, MD, PhD, National Cancer Institute, Bethesda, Maryland
John Sunderland, PhD, University of Iowa, University of Iowa Carver College of Medicine, Iowa City, Iowa)
Jerold Wallis, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
Dean Wong, MD, PhD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
Anna Wu, PhD, Beckman Research Institute of City of Hope, Duarte, California
Katherine Zukotynski, MD, PhD, Peng, McMaster University, Hamilton, Canada
Selection of SNMMI Fellows is based on documented excellence of volunteer service to the society and at least one of the additional three areas: excellence in scientific discovery and innovation, educational efforts in nuclear medicine and molecular imaging, or clinical practice of nuclear medicine and molecular imaging. SNMMI Fellowship is recognized with the designation FSNMMI.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.